Canadian Consensus Statements on the Transition of Adolescents and Young Adults with Inflammatory Bowel Disease from Pediatric to Adult Care: A Collaborative Initiative Between the Canadian IBD Transition Network and Crohn's and Colitis Canada.

Autor: Fu N; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Bollegala N; Division of Gastroenterology, Department of Medicine, Women's College Hospital, Toronto, Ontario, Canada., Jacobson K; Division of Gastroenterology, Hepatology and Nutrition, BC Children's Hospital, Vancouver, British Columbia, Canada., Kroeker KI; Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., Frost K; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada., Afif W; Division of Gastroenterology, Department of Medicine, McGill University, Montreal, Quebec, Canada., El-Matary W; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, Manitoba, Canada., Fowler SA; Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada., Griffiths AM; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada., Huynh HQ; Division of Pediatric GI Nutrition, Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada., Jantchou P; Division of Gastroenterology, Department of Pediatrics, CHU Sainte-Justine, Montréal, Quebec, Canada., Karimuddin A; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada., Nguyen GC; Department of Medicine, Mount Sinai Hospital Inflammatory Bowel Disease Centre, University of Toronto, Toronto, Ontario, Canada., Otley AR; Division of Pediatric Gastroenterology & Nutrition, IWK Health Centre, Halifax, Nova Scotia, Canada., Pears C; IBD Centre BC, Vancouver, British Columbia, Canada., Seow CH; Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada., Toulany A; Division of Adolescent Medicine, Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada., Tersigni C; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Tignanelli J; Patient Partner, Ontario, Canada., Marshall JK; Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada., Boctor M; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Hansen T; Department of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Pattni C; Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Wong A; University of British Columbia, Vancouver, British Columbia, Canada., Benchimol EI; Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.

Publikováno v: Journal of the Canadian Association of Gastroenterology [J Can Assoc Gastroenterol] 2022 Mar 26; Vol. 5 (3), pp. 105-115. Date of Electronic Publication: 2022 Mar 26 (Print Publication: 2022).

Inhibition of the mitochondrial pyruvate carrier simultaneously mitigates hyperinflammation and hyperglycemia in COVID-19.

Autor: Zhu, Bibo, Wei, Xiaoqin, Narasimhan, Harish, Qian, Wei, Zhang, Ruixuan, Cheon, In Su, Wu, Yue, Li, Chaofan, Jones, Russell G., Kaplan, Mark H., Vassallo, Robert A., Braciale, Thomas J., Somerville, Lindsay, Colca, Jerry R., Pandey, Akhilesh, Jackson, Patrick E. H., Mann, Barbara J., Krawczyk, Connie M., Sturek, Jeffrey M., Sun, Jie

Publikováno v: Science Immunology; 2023, Vol. 8 Issue 82, p1-16, 16p

The possible role of nuclear factor erythroid-2-related factor 2 activators in the management of Covid-19.

Autor: Al-Kuraishy HM; Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Iraq., Al-Gareeb AI; Department of Clinical Pharmacology and Medicine, College of Medicine, ALmustansiriyia University, Iraq., Eldahshan OA; Department of Pharmacognosy, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo, Egypt., Abdelkhalek YM; Faculty of Dentistry, Ain Shams University, Cairo, Egypt., El Dahshan M; Department of Internal Medicine, Faculty of Medicine, Al Azhar University, Cairo, Egypt., Ahmed EA; Department of Pharmacology, Faculty of Veterinary Medicine, Suez Canal University, Ismailia, Egypt., Sabatier JM; Institut de Neurophysiopathologie (INP), CNRS UMR 7051, Faculté des Sciences Médicales et Paramédicales, Aix-Marseille Université, Marseille, France., Batiha GE; Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, AlBeheira, Egypt.

Publikováno v: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2024 Jan; Vol. 38 (1), pp. e23605. Date of Electronic Publication: 2023 Dec 09.

Local iontophoretic administration of cytotoxic therapies to solid tumors.

Autor: Byrne, James D., Jajja, Mohammad R. N., O’Neill, Adrian T., Bickford, Lissett R., Keeler, Amanda W., Hyder, Nabeel, Wagner, Kyle, Deal, Allison, Little, Ryan E., Moffitt, Richard A., Stack, Colleen, Nelson, Meredith, Brooks, Christopher R., Lee, William, Luft, J. Chris, Napier, Mary E., Darr, David, Anders, Carey K., Stack, Richard, Tepper, Joel E.

Publikováno v: Science Translational Medicine; 2/4/2015, Vol. 7 Issue 273, p1-10, 10p, 1 Color Photograph, 4 Graphs